Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityNo recent work listed

Weiyang Lou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4848-9891; OpenAlex author ID A5023249241. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 3

  1. A key regulatory loop AK4P1/miR-375/SP1 in pancreatic adenocarcinoma. First author DOI 10.1080/15592294.2022.2148433↗
  2. Construction of a lncRNA/pseudogene-hsa-miR-30d-5p-GJA1 regulatory network related to metastasis of pancreatic cancer. Last author DOI 10.1016/j.ygeno.2021.04.013↗
  3. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer. First author DOI 10.18632/aging.101933↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Linhang Mei · 1 shared paper, 2023 · strength 0.31
  2. Wangjin Xu · 1 shared paper, 2023 · strength 0.31
  3. Huilin Zheng · 1 shared paper, 2021 · strength 0.17
  4. Ke Xue · 1 shared paper, 2021 · strength 0.17
  5. Weimin Fan · 1 shared paper, 2019 · strength 0.11
  6. Wenlong Wang · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.